Collaborators at the University of Melbourne and Peter MacCallum Cancer Centre developing a liquid biopsy test for cancer of unknown primary
More than a quarter of cases in the Australian Cerebral Palsy Biobank traced to gene variation
How a 25-year-old diagnosed with Stage IV cancer was matched with a clinical trial and targeted therapy—and, nine years later, is now a dad
Donations driven by Illumina employees contributed $122,000 to Singaporean charities in 2023
The Illumina Microbial Amplicon Prep simplifies a public health laboratory’s efforts to track the virus
| Date | Publication | Title |
|---|---|---|
| Oct 26, 2024 | China Science and Technology News Network | Illumina Appears at the 2024 CSCO Annual Meeting, Illuminating the Future of Precision Oncology with Genomics |
| Oct 23, 2024 | Inside Precision Heath Medicine | Quad Moonshot First Targets Cervical Cancer |
| Sep 19, 2024 | BioPharma APAC | Illumina and LGC Biosearch Technologies Forge Strategic Partnership to Advance Agricultural Genomics |
| Sep 17, 2024 | Pharmaphorum | ESMO: Interview with Sven Schaffer |
| Sep 9, 2024 | OncLive | FDA Approves TruSight Oncology Comprehensive Assay As Pan-Tumor Companion Diagnostic |
At Illumina, we push boundaries. We think beyond the conventional. We dream big. With the energy of so many bright and accomplished people, the opportunities are endless.
Search for JobsIf you are a member of the media:
If you are not a member of the media, please visit Contact Us.
